Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

SELL
$61.48 - $73.72 $377,302 - $452,419
-6,137 Closed
0 $0
Q2 2020

Jul 16, 2020

SELL
$54.82 - $64.09 $215,607 - $252,065
-3,933 Reduced 39.06%
6,137 $361,000
Q4 2019

Jan 15, 2020

BUY
$49.21 - $64.19 $495,544 - $646,393
10,070 New
10,070 $646,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Profit Investment Management, LLC Portfolio

Follow Profit Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profit Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profit Investment Management, LLC with notifications on news.